The Mazda Pharma Guide 7th October to 13th October | Page 62

?AR M AC
?
PH
peptides.”

EU

TIC

AL N

EW

S

award is a testimonial to the team's vigour and

“Ipsen is honored and eager to join the
Cambridge community, home to scientific

pursuant to which Actavis has agreed to divest

zeal and the company's customer centricity.”

certain products as a condition to obtaining

The award came in as recognition of

FTC approval. The closing of the transaction

excellence and unparalleled medical

the company's initiative to empower its sales

remains subject to approval by the Irish High

innovation,” said Cynthia Sylvestre, president,

force for delivering unparalleled customer

Court and other customary closing conditions,

Biomeasure and vice president and Milford

experience and for flawless execution of

and is expected to occur as soon as practicable

Site Head, Ipsen. “This move reflects our

project Veeva. The project was designed to

after satisfaction of those conditions. Under

commitment to remain at the cutting edge of

empower the sales team of approximately 300

the terms of the consent order with the FTC

research and development to ultimately

to be self-dependant through relevant modular

and subject to the consummation of the

provide life-saving therapies to patients in

tool iPad & compatible CRM system Veeva.

need.”

The system helped enhance customer
The company signed an eleven year

transaction between Actavis and Warner
Chilcott, Actavis will divest four products to

interaction by leveraging multimedia

Amneal Pharmaceuticals. Terms of the

lease on 62,600 rentable square-feet of

platform, real time reporting, well

divestitures were not disclosed.

laboratory and office space within the 280,000

documented coaching reports and using

square-foot building located at 650 East

advanced analytics to eliminate the struggle of

Zenchent Fe (norethindrone acetate/ethinyl

Kendall Street. The deal was brokered by

the sales representative for doctor's attention.

estradiol), a generic version of Femcon Fe;

Cresa Corporate Real Estate and the property

The system also adequately equipped the sales

Actavis' pending application for

is owned by BioMed Realty Trust Inc.

representatives with micro details to monitor

norethindrone acetate/ethinyl estradiol, a

Ipsen is a global specialty-driven

each SFE metric leading to efficient and

generic version of Lo Loestrin Fe. This

pharmaceutical company and aims to become

effective planning. Much-coveted OPPI award

product application remains subject to

a leader in specialty healthcare solutions for

was bagged by the project for achieving

pending patent litigation pursuant to the

targeted debilitating diseases.

remarkable success and flawless execution of

provisions of the Hatch Waxman Act: Actavis'

the project while carefully aligning the sales

pending application for risedronate sodium, a

function with all other relevant functions and

generic version of Atelvia. This product

accordingly implementing Organisation

application remains subject to pending patent

Change Management (OCM).

litigation pursuant to the provisions of the

ELI LILLY'S VEEVA
BAGS OPPI SALES
FORCE EXCELLENCE
AWARD 2013
Mumbai : To promote excellence in
pharmaceutical selling in 2012, Eli Lilly and
Company - India, the leading innovation based
pharmaceutical player, has won the OPPI
Sales Force Excellence Award 2013 for its

Lilly, a leading innovation-driven

application for norethindrone acetate/ethinyl

of pharmaceutical products by applying the

estradiol, a generic version of Loestrin 24 Fe.

latest research from its own worldwide

This product is the subject of a settlement

laboratories and from collaborations with

agreement that resolved patent litigation,

eminent scientific organisations.

pursuant to which the product may be

US FEDERAL TRADE

unparalleled customer experience by

COMMISSION

Lilly India recently conferred at
OPPI's AGM held in Mumbai.
Commenting on this achievement,
Edgard Olaizola, managing director, Lilly
India, said, “It